12 Feb 2009 05:00 AM
New England Journal Of Medicine Publishes Results From The Landmark ATHENA Trial With Multaq(R) (dronedarone) In Atrial Fibrillation
Sanofi Aventis (Paris Bourse: EURONEXT: SAN; and New York: NYSE: SNY) announced that the ATHENA trial was published in the New England Journal of Medicine…

